Detailed information for compound 2181618

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 282.148 | Formula: C16H18N4O
  • H donors: 2 H acceptors: 2 LogP: 2.61 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 0
  • SMILES: CCc1cccc(c1)NCC(=O)N/N=C/c1ccncc1
  • InChi: InChI=1S/C16H18N4O/c1-2-13-4-3-5-15(10-13)18-12-16(21)20-19-11-14-6-8-17-9-7-14/h3-11,18H,2,12H2,1H3,(H,20,21)/b19-11+
  • InChiKey: QBVRFKUXWPJCLL-YBFXNURJSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adrenergic, beta, receptor kinase 1 No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus beta-adrenergic receptor kinase Get druggable targets OG5_131467 All targets in OG5_131467
Schistosoma japonicum G protein-coupled receptor kinase 1, putative Get druggable targets OG5_131467 All targets in OG5_131467
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_131467 All targets in OG5_131467
Schistosoma japonicum hypothetical protein Get druggable targets OG5_131467 All targets in OG5_131467
Echinococcus granulosus G protein coupled receptor kinase 1 Get druggable targets OG5_131467 All targets in OG5_131467
Echinococcus multilocularis beta adrenergic receptor kinase Get druggable targets OG5_131467 All targets in OG5_131467
Schistosoma japonicum ko:K00924 G-protein-coupled Receptor Kinase [EC:2.7.1.-], putative Get druggable targets OG5_131467 All targets in OG5_131467
Echinococcus multilocularis G protein coupled receptor kinase 1 Get druggable targets OG5_131467 All targets in OG5_131467
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_131467 All targets in OG5_131467
Loa Loa (eye worm) AGC/GRK/BARK protein kinase Get druggable targets OG5_131467 All targets in OG5_131467

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis conserved hypothetical protein 0.0012 0 0.5
Echinococcus multilocularis beta adrenergic receptor kinase 0.0112 1 1
Entamoeba histolytica hypothetical protein 0.0012 0 0.5
Schistosoma mansoni serine/threonine protein kinase 0.0112 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0012 0 0.5
Brugia malayi Probable G protein-coupled receptor kinase F19C6.1, putative 0.0012 0.0028 1
Entamoeba histolytica hypothetical protein 0.0012 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0012 0 0.5
Schistosoma mansoni serine/threonine protein kinase 0.0012 0.0028 0.0028
Entamoeba histolytica hypothetical protein 0.0012 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0012 0 0.5
Loa Loa (eye worm) AGC/GRK/GRK protein kinase 0.0012 0.0028 0.0028
Echinococcus granulosus G protein coupled receptor kinase 1 0.01 0.8846 0.8846
Schistosoma mansoni serine/threonine protein kinase 0.0112 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0012 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0012 0 0.5
Loa Loa (eye worm) AGC/GRK/BARK protein kinase 0.0112 1 1
Echinococcus multilocularis G protein coupled receptor kinase 1 0.01 0.8846 0.8846
Trichomonas vaginalis regulator of G protein signaling 5, rgs5, putative 0.0012 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 1000 nM Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.